Most would agree that EU #pharma legislation needs a makeover, but what is the right approach? We take a look at the EC's long-anticipated proposals and how stakeholders are reacting. https://buff.ly/3szFCwN #regulations #EU #EC #EuropeanUnion
À propos
Bionest Partners is a global consulting firm focused on Pharma, Biotech, Medical Device and Diagnostics that helps clients navigate complex product development issues in order to drive growth, create value and gain competitive advantage. We also offer our expertise and analytic skills to support investors with due diligence assignments in these markets. Bionest consultants are valued strategic partners who have helped more than 250 companies around the world build high-value product portfolios, optimize development approaches and prepare for commercial success. Our track record includes more than 500 successful projects consisting of innovative, creative and differentiated action plans grounded in in-depth market and financial analysis. Our collaborative and hands-on approach allows us to be flexible and tailor our approach to your needs. This results in practical solutions complete with deep analysis, clear recommendations, and solid strategies that recognize the process of gaining internal alignment at the corporate, portfolio and brand levels. Using our creativity and insights combined with deep content experience and a global focus, we have the right knowledge and experience to help you succeed.
- Site web
-
http://www.bionest.com
Lien externe pour Bionest Partners
- Secteur
- Services et conseil aux entreprises
- Taille de l’entreprise
- 11-50 employés
- Siège social
- Paris
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2003
- Domaines
- life sciences, health, pharma, drug development et business
Lieux
-
Principal
19 Rue du Genral foy
75008 Paris, FR
-
380 Lexington
10005 New York, NY, US